Anzeige
Mehr »
Montag, 09.03.2026 - Börsentäglich über 12.000 News
Verdoppelt - und noch nicht am Ziel? Dieser Rohstoff-Explorer profitiert vom Antimon-Boom
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
21:30Jefferies reiterates Sarepta stock Buy rating on DMD data1
21:30Prothena earns $50M milestone from Novo Nordisk for drug trial1
21:30Coherus BioSciences Non-GAAP EPS of -$0.34 misses by $0.03, revenue of $12.7M misses by $1.39M3
21:30Xenon Pharmaceuticals launches $500 million stock offering1
21:30Earnings Breakdown: Septerna Q41
21:28ZEVRA THERAPEUTICS, INC. - S-8, Securities to be offered to employees in employee benefit plans-
21:23ZEVRA THERAPEUTICS, INC. - 10-K, Annual Report3
21:22Jefferies bekräftigt Kaufempfehlung für Sarepta nach neuen DMD-Studiendaten1
21:18Coherus Oncology, Inc.: Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update1
21:18Insights into Coherus Oncology Q4 Earnings1
21:18Zevra Therapeutics Q4 Earnings Report: What Investors Need to Know1
21:18BioNTech Q4 2025 Earnings Preview6
21:18Earnings Summary: Septerna Q45
21:17Design Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
21:12Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 20261
21:12Zevra Therapeutics: Zevra Reports Fourth Quarter and Full Year 2025 Financial Results6
21:12Septerna, Inc.: Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results2
21:12Septerna, Inc. - 10-K, Annual Report1
21:09Larimar Therapeutics, Inc. - 8-K, Current Report1
21:09Design Therapeutics, Inc. - 10-K, Annual Report5
Weiter >>